Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2008-05-20
2008-05-20
Lucas, Zachariah (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S184100, C424S185100, C424S186100
Reexamination Certificate
active
07374766
ABSTRACT:
The present invention is related to the branch of medicine, particularly to the new formulations of vaccine antigens.The technical objective pursued with the present invention is, precisely, the development of formulations that are able to enhance the immune response to mucosally administered antigens, minimising the number of compounds in the formulation and generating strong mucosal and systemic responses through a synergic interaction between the antigens in the formulation.These formulations enable: a) to broaden the spectrum of the anti-hepatitis B immune response, containing as main compounds HBsAg and HBcAg, b) to enhance the response against HBsAg with a viral nucleocapsid c) to generate combined vaccines through the mucosal route with HBsAg as a central antigen. Stabilizers and preservatives can be introduced.The formulations of this invention can be applied in the pharmaceutical industry as human or veterinary vaccine formulations.
REFERENCES:
patent: 4547368 (1985-10-01), Tabor et al.
patent: 5618536 (1997-04-01), Lowy et al.
patent: 5840303 (1998-11-01), Chisari et al.
patent: 5932224 (1999-08-01), Chisari
patent: 5962428 (1999-10-01), Carrano et al.
patent: 5972346 (1999-10-01), Hauser et al.
patent: 6025341 (2000-02-01), Wands et al.
patent: 6048536 (2000-04-01), Chatfield
patent: 6126938 (2000-10-01), Guy et al.
patent: 6153201 (2000-11-01), Rose et al.
patent: 6153392 (2000-11-01), Liao et al.
patent: 6261765 (2001-07-01), McCarthy et al.
patent: 6319501 (2001-11-01), Neurath et al.
patent: 6436402 (2002-08-01), Zhao et al.
patent: 0 271 302 (1988-06-01), None
patent: 0 534 615 (1993-03-01), None
patent: 0 835 663 (1998-04-01), None
patent: 0 835 663 (1999-03-01), None
patent: WO 94/12617 (1994-06-01), None
Dorland's Illustrated Medical Dictionary, 28 edition. Philadelphia, WB Saunders, 1994, p. 1787.
Fields et al. Virology, vol. 1, 3rd edition, Philadelphia, Lippencott, Williams, and Wilkins, publishers. 1996: p. 1356.
Lanford et al. ILAR Journal. 2001; 42 (2): 117-26, abstract only.
Coursaget et al. Cancer Surveys. 1998; 33: 355-381, abstract only.
Farrell. Drugs. 2000; 60 (4): 701-710.
Fields et al. Virology, vol. 1, 3rd edition, Philadelphia, Lippencott, Williams, and Wilkins, publishers. 1996: p. 2705.
Harrison et al. Virus Structure. In B.N. Fields et al. (ed.), Fields Virology, 3rd ed. Philadelphia: Lippencott-Raven Publishers; 1996: 60.
Bowen et al. Research in Virology. 1992; 143 (4): 269-78, abstract only.
Lanford et al. ILAR Journal. 2001; 42 (2): 117-26, abstract only.
Parr Canadian Journal of Gastroenterology. 2000; 14 Suppl B: 83B-88B, abstract only.
Houghton et al. “Prospects for a vaccine against the hepatitis C virus,” Nature, vol. 436, Aug. 18, 2005.
McCluskie et al., “Immunization Against Hepatitis B Virus by Mucosal Administration of Antigen-Antibody Complexes,” Viral Immunology, vol. 11, No. 4, 1998, pp. 245-252.
Roden et al. “Preventative and therapeutic vaccines for cervical cancer,” Expert Rev. of Vaccines, 2(4): 496-516 (Aug. 2003.
Milich et al., “Antibody production to the nucleocapsid and envelope of the Hepatitis B virus primed by a single synthetic T cell site,” Nature, vol. 329, pp. 547-549 (1987).
Aguilar Rubido Julio César
Guillén Nieto Gerardo E.
Iglesias Perez Enrique
Muzio González Verena L.
Palenzuela Gardón Daniel O.
Centro de Ingenieria Genetic y Biotechnologia
Hoffmann & Baron , LLP
Lucas Zachariah
Peng Bo
LandOfFree
Compositions containing virus-like particles as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions containing virus-like particles as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions containing virus-like particles as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2760354